Catalyst Pharmaceuticals Inc. Insider Trading

CPRX

Last 12 months

Insiders sold $1.79M and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Chief Compliance/Legal Officer Brian Elsbernd sold 908K on Nov 12, 2025, 21% of their stake, outside a plan. The last open-market buy by an executive or director was in Sep 2020.

Net open-market

−$1.79M

0 buys · 3 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 3

executives and directors

Last open-market buy

Sep 2020

Sep 30, 2020

Get an email when CPRX's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Dec 12, 2025	Molly Harper Director	SoldNo plan 3 parts	26,746	$23.25 average	622K	92%	Form 4
Nov 26, 2025	Jeffrey Del Carmen Chief Commercial Officer	SoldNo plan	10,983	$23.33	256K	73%	Form 4
Nov 12, 2025	Brian Elsbernd Chief Compliance/Legal Officer	SoldNo plan	40,000	$22.70	908K	21%	Form 4
Sep 8, 2025	Brian Elsbernd Chief Compliance/Legal Officer	SoldNo plan	30,000	$20.30	609K	10.0%	Form 4
Sep 3, 2025 – Sep 4, 2025	Brian Elsbernd Chief Compliance/Legal Officer	SoldNo plan 2 parts	50,000	$19.74 average	987K	21%	Form 4
Aug 27, 2025	David S Tierney Director	SoldNo plan	26,000	$20.20	525K	6.4%	Form 4
Aug 26, 2025	Steve Miller Chief Op. & Scientific Officer	SoldNo plan	115,000	$20.28	$2.33M	9.8%	Form 4
Aug 26, 2025	Richard J Daly President and CEO	SoldNo plan	22,970	$20.62	474K	9.2%	Form 4
Jun 10, 2025 – Jun 11, 2025	Preethi Sundaram Chief Strategy Officer	SoldNo plan 2 parts	3,924	$26.41 average	104K	8.7%	Form 4
Jun 6, 2025 – Jun 9, 2025	Patrick J McEnany Director	SoldNo plan 2 parts	200,000	$26.09 average	$5.22M	4.5%	Form 4
May 30, 2025	Richard J Daly President and CEO	SoldNo plan	70,000	$24.86	$1.74M	54%	Form 4
May 13, 2025 – May 14, 2025	Gary Ingenito Chief Med. & Reg. Officer	SoldNo plan 2 parts	244,000	$23.67 average	$5.78M	78%	Form 4
Mar 5, 2025 – Mar 6, 2025	Gary Ingenito Chief Med. & Reg. Officer	SoldNo plan 2 parts	225,000	$21.75 average	$4.89M	77%	Form 4
Mar 3, 2025	Brian Elsbernd Chief Compliance/Legal Officer	SoldNo plan 2 parts	62,975	$22.98 average	$1.45M	25%	Form 4
Mar 3, 2025	Jeffrey Del Carmen Chief Commercial Officer	SoldNo plan	30,423	$22.89	696K	100%	Form 4
Dec 10, 2024	Steve Miller Chief Op. & Scientific Officer	SoldNo plan	50,000	$21.93	$1.1M	6.8%	Form 4
Nov 27, 2024	Gary Ingenito Chief Med. & Reg. Officer	SoldNo plan 2 parts	12,000	$22.72 average	273K	19%	Form 4
Nov 27, 2024	Molly Harper Director	SoldNo plan	17,500	$22.00	385K	100%	Form 4
Nov 26, 2024	Brian Elsbernd Chief Compliance/Legal Officer	SoldNo plan 2 parts	13,256	$21.63 average	287K	7.2%	Form 4
Nov 20, 2024	Gary Ingenito Chief Med. & Reg. Officer	SoldNo plan	38,000	$21.20	806K	43%	Form 4
Nov 19, 2024 – Nov 20, 2024	Patrick J McEnany Director	SoldNo plan 2 parts	170,845	$21.23 average	$3.63M	3.7%	Form 4
Nov 13, 2024 – Nov 14, 2024	Patrick J McEnany Director	SoldNo plan 2 parts	137,155	$22.58 average	$3.1M	3.0%	Form 4
Nov 11, 2024 – Nov 12, 2024	Patrick J McEnany Director	SoldNo plan 3 parts	492,000	$23.39 average	$11.5M	9.9%	Form 4

Dec 12, 2025No plan
Molly Harper
Director · sold 26,746 at avg $23.25
622K
92% of stake
Nov 26, 2025No plan
Jeffrey Del Carmen
Chief Commercial Officer · sold 10,983 at $23.33
256K
73% of stake
Nov 12, 2025No plan
Brian Elsbernd
Chief Compliance/Legal Officer · sold 40,000 at $22.70
908K
21% of stake
Sep 8, 2025No plan
Brian Elsbernd
Chief Compliance/Legal Officer · sold 30,000 at $20.30
609K
10.0% of stake
Sep 3, 2025 – Sep 4, 2025No plan
Brian Elsbernd
Chief Compliance/Legal Officer · sold 50,000 at avg $19.74
987K
21% of stake
Aug 27, 2025No plan
David S Tierney
Director · sold 26,000 at $20.20
525K
6.4% of stake
Aug 26, 2025No plan
Steve Miller
Chief Op. & Scientific Officer · sold 115,000 at $20.28
$2.33M
9.8% of stake
Aug 26, 2025No plan
Richard J Daly
President and CEO · sold 22,970 at $20.62
474K
9.2% of stake
Jun 10, 2025 – Jun 11, 2025No plan
Preethi Sundaram
Chief Strategy Officer · sold 3,924 at avg $26.41
104K
8.7% of stake
Jun 6, 2025 – Jun 9, 2025No plan
Patrick J McEnany
Director · sold 200,000 at avg $26.09
$5.22M
4.5% of stake
May 30, 2025No plan
Richard J Daly
President and CEO · sold 70,000 at $24.86
$1.74M
54% of stake
May 13, 2025 – May 14, 2025No plan
Gary Ingenito
Chief Med. & Reg. Officer · sold 244,000 at avg $23.67
$5.78M
78% of stake
Mar 5, 2025 – Mar 6, 2025No plan
Gary Ingenito
Chief Med. & Reg. Officer · sold 225,000 at avg $21.75
$4.89M
77% of stake
Mar 3, 2025No plan
Brian Elsbernd
Chief Compliance/Legal Officer · sold 62,975 at avg $22.98
$1.45M
25% of stake
Mar 3, 2025No plan
Jeffrey Del Carmen
Chief Commercial Officer · sold 30,423 at $22.89
696K
100% of stake
Dec 10, 2024No plan
Steve Miller
Chief Op. & Scientific Officer · sold 50,000 at $21.93
$1.1M
6.8% of stake
Nov 27, 2024No plan
Gary Ingenito
Chief Med. & Reg. Officer · sold 12,000 at avg $22.72
273K
19% of stake
Nov 27, 2024No plan
Molly Harper
Director · sold 17,500 at $22.00
385K
100% of stake
Nov 26, 2024No plan
Brian Elsbernd
Chief Compliance/Legal Officer · sold 13,256 at avg $21.63
287K
7.2% of stake
Nov 20, 2024No plan
Gary Ingenito
Chief Med. & Reg. Officer · sold 38,000 at $21.20
806K
43% of stake
Nov 19, 2024 – Nov 20, 2024No plan
Patrick J McEnany
Director · sold 170,845 at avg $21.23
$3.63M
3.7% of stake
Nov 13, 2024 – Nov 14, 2024No plan
Patrick J McEnany
Director · sold 137,155 at avg $22.58
$3.1M
3.0% of stake
Nov 11, 2024 – Nov 12, 2024No plan
Patrick J McEnany
Director · sold 492,000 at avg $23.39
$11.5M
9.9% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch CPRX, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with CPRX

CompareIntrinsic value

TVTXTravere Therapeutics Inc.

$52.64+6.54%52

OPKOpko Health Inc.

$1.77+2.91%25

MIRMMirum Pharmaceuticals Inc.

$95.00+9.16%30

FOLDAmicus Therapeutics, Inc.

No recent price45

HCMHUTCHMED (China) Ltd

$13.92+6.42%45

ARWRArrowhead Pharmaceuticals Inc.

$61.65+3.56%40

VREOFVireo Growth Inc.

$7.29-2.15%30

NATRNature's Sunshine Products Inc.

$12.84+6.38%70

Held by ETFs

CPRX is in 31 US ETFs. The largest of them, with CPRX's weight in each:

Spot a number that looks wrong? Check it in CPRX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing CPRX

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.